Notice Number: NOT-DK-18-009

Key Dates
Release Date: January 17, 2018

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to inform applicants that NIDDK will no longer be participating in PAR-18-530: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) and will not accept applications for the first Application Due Date (March 8, 2018) nor any subsequent Standard Due Dates.

The following changes have been made to reflect NIDDK's withdrawal from this announcement.

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (removed)

Catalog of Federal Domestic Assistance (CFDA) Numbers
93.394, 93.395, 93.286, 93.242, 93.847 (removed)

In Section VII. Agency Contacts, NIDDK's Scientific/Research and Grants Management contacts should be disregarded for this announcement.

All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Jose Serrano, M.D., Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8871
Email: [email protected]